fashion -WSS

fashion

author：hotspot 2025-10-01 06:01:16 - browse：4

Immunofluorescence image shows CD4+ (green) and CD8+ (yellow) T cells in the microenvironment of a head and neck squamous cell carcinoma. — This immunofluorescence image shows T cells (in green and yellow) in the microenvironment of a head and neck squamous cell carcinoma. Allen Lab/NCI/NIH

Merus said Tuesday that the combination of its experimental drug petosemtamab with the checkpoint inhibitor Keytruda shrank tumors in 62% of patients with head and neck cancer, according to an interim analysis of an ongoing mid-stage clinical trial.

The new efficacy results, derived from a larger number of patients, look similar to an initial disclosure made last week that triggered a 36% increase in Merus’ stock price.

But the Dutch drugmaker on Tuesday withheld additional information from the study related to the safety and durability of petosemtamab’s tumor responses, pending presentation at the annual meeting of the American Society of Clinical Oncology on June 3.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： BioMarin wins approval for gene therapy to treat hemophilia A
Next article： 'The Exorcist' director William Friedkin dead at 87

WSS

Cuban government calls US nuclear submarine stop a 'provocative escalation'

China sends large group of warplanes, navy ships towards Taiwan in forceful display

Antibody drugs appear effective. Now can we make enough of them?

Judges halt a Biden rule offering student debt relief for those alleging colleges misled them

Democratic lawmaker calls for 'well

Thousands in Haiti march to demand safety from violent gangs as killings and kidnappings soar

Wikipedia

fashion

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

knowledge

Apple is now the first public company to be valued at $3 trillion

Trump Jan. 6 attorney John Lauro is ex

Sports medicine is finally prioritizing gender equality

France's anti

BioMarin wins approval for gene therapy to treat hemophilia A

Thousands of Marines and sailors deploy to Middle East to deter Iran from seizing ships

Affirmative action in medical school literally saved lives

Biden will tout long

Tori Bowie and the unacceptable rates of Black maternal death

Va. Republicans encourage early voting, a target of Trump's, ahead of fall elections

focus

France's anti

Tesla CFO Zachary Kirkhorn steps down, but will remain with company through year's end

Bursting ice dam in Alaska highlights risks of glacial flooding around the globe

Blinken talks high

Kerry to visit Beijing for climate talks amid efforts to revive relations between US and China

Grail's uphill battle for Medicare to cover its cancer screening test

hotspot

hotspot

hotspot

focus